<DOC>
	<DOCNO>NCT00314405</DOCNO>
	<brief_summary>The aim study evaluate performance double label method use isotope methylene blue dye injection localize precisely Sentinel Lymph Node ( SLN ) series 100 patient infiltrative breast cancer justify SLN excision . Method patient : SLN excision perform 100 patient treat infiltrative breast cancer . After preoperative methylene blue dye injection lymphoscintigraphy , individual localization radioactive stain node perform . After surgery , SLN submit serial analysis immunohistochemistry . A comparison two method economical evaluation complete procedure perform .</brief_summary>
	<brief_title>Identification Sentinel Lymph Nodes With Methylene Blue Isotope</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>patient infiltrative breast cancer ( diagnose preoperatively core biopsy ) approval inform consent chemotherapy locoregional radiotherapy prevalent axillary lymph node</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>sentinel lymph node</keyword>
	<keyword>SLN</keyword>
	<keyword>probe</keyword>
	<keyword>breast cancer</keyword>
	<keyword>lymphoscintigraphy</keyword>
	<keyword>methylene blue dye</keyword>
</DOC>